NCT00422669

Optimize RV Selective Site Pacing Clinical Trial

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 205 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the Optimize RV study is to determine the long-term effect of selective site pacing. Selective site pacing refers to which area of the right ventricle the lead is placed. The goal of select site pacing is to improve how the heart contracts when paced in the ventricle. By pacing in select sites, it is possible to better copy the natural pattern of contraction of the heart.

Conditions

• Cardiac Pacing, Artificial
• Cardiac Pacemaker, Artificial

Interventions

Type	Name	Description
DEVICE	Medtronic Dual-Chamber Pacemaker	A Medtronic market-approved dual-chamber implantable pulse generator (IPG)
DEVICE	Medtronic SelectSecure 3830 Lead	Medtronic market-approved SelectSecure Model 3830 bipolar pacing lead

Timeline

• Start date: 2007-01-01
• Primary completion: 2009-05-01
• Completion: 2009-05-01
• First posted: 2007-01-17
• Last updated: 2013-01-31
• Results posted: 2012-11-01

Locations

22 sites across 6 countries: United States, Canada, China, Israel, Italy, Qatar